Downstream processing of recombinant proteins from transgenic feedstock.

Area of Science:

• Biotechnology
• Molecular Biology
• Biopharmaceutical Production

Background:

• The demand for affordable large-scale recombinant protein production has driven innovation in transgenic systems.
• Transgenic plants and animals have emerged as viable platforms for producing therapeutic proteins over the last decade.

Purpose of the Study:

• To review the advancements in transgenic technology platforms for recombinant protein production.
• To highlight the ongoing improvements in protein expression and product recovery.
• To identify future cost-saving strategies focusing on downstream processing.

Main Methods:

• Review of existing literature on transgenic plant and animal systems for protein expression.
• Analysis of technological advancements in expression and purification methods.
• Evaluation of cost-effectiveness in biopharmaceutical manufacturing.

Main Results:

• Transgenic systems in plants and animals have successfully produced multiple therapeutic proteins.
• Continuous improvements in protein expression levels and recovery processes are evident.
• Downstream processing represents a key area for future cost reduction.

Conclusions:

• Transgenic technology platforms provide a cost-effective means for producing recombinant proteins.
• Further optimization of downstream processing is crucial for enhancing the economic viability of these systems.
• The field is advancing towards more efficient and economical biopharmaceutical manufacturing.